Your browser doesn't support javascript.
loading
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial.
Lorusso, D; Ferrandina, G; Colombo, N; Pignata, S; Pietragalla, A; Sonetto, C; Pisano, C; Lapresa, M T; Savarese, A; Tagliaferri, P; Lombardi, D; Cinieri, S; Breda, E; Sabatucci, I; Sabbatini, R; Conte, C; Cecere, S C; Maltese, G; Scambia, G.
Afiliación
  • Lorusso D; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Electronic address: domenica.lorusso@policlinicogemelli.it.
  • Ferrandina G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Woman, Child and Public Health, Catholic University of the Sacred Heart, Rome, Italy.
  • Colombo N; Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of medicine and surgery, University of Milan-Bicocca, Milan, Italy.
  • Pignata S; Department of Oncology, Fondazione Pascale National Cancer Institute, Naples, Italy.
  • Pietragalla A; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Sonetto C; Gynecologic Oncology Unit, Fondazione IRCCS National Cancer Institute, Milan, Italy.
  • Pisano C; Department of Oncology, Fondazione Pascale National Cancer Institute, Naples, Italy.
  • Lapresa MT; Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Savarese A; Department of Oncology, Regina Elena National Cancer Institute, Rome, Italy.
  • Tagliaferri P; Department of Oncology, Magna Grecia University, Catanzaro, Italy.
  • Lombardi D; Department of Oncology, CRO, Aviano, Italy.
  • Cinieri S; Department of Oncology, Di Summa-Perrino Hospital, Brindisi, Italy.
  • Breda E; Department of Oncology, Fatebenefratelli Hospital, Rome, Italy.
  • Sabatucci I; Gynecologic Oncology Unit, Fondazione IRCCS National Cancer Institute, Milan, Italy.
  • Sabbatini R; Department of Oncology, University of Modena and Reggio Emilia, Italy.
  • Conte C; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Cecere SC; Department of Oncology, Fondazione Pascale National Cancer Institute, Naples, Italy.
  • Maltese G; Gynecologic Oncology Unit, Fondazione IRCCS National Cancer Institute, Milan, Italy.
  • Scambia G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Woman, Child and Public Health, Catholic University of the Sacred Heart, Rome, Italy.
Gynecol Oncol ; 155(3): 406-412, 2019 12.
Article en En | MEDLINE | ID: mdl-31677820
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Endometriales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Endometriales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article